Ali-Jackson Kamil

Director at RIGEL PHARMACEUTICALS INC · on record since May 19, 2026
Chief Legal Officer at Aclaris Therapeutics, Inc. · on record since Dec 22, 2015
Director at Edge Therapeutics, Inc. · on record since Feb 24, 2020

Insider trading activity of Ali-Jackson Kamil

Transactions on record: 135; since Oct 13, 2015

Open-market buys: 1; $100K

Open-market sells: 25; $3.3M

Companies traded: 3; last filing Jun 24, 2026

Figures computed from official regulatory filings — methodology.

Companies where Ali-Jackson Kamil has traded

RIGEL PHARMACEUTICALS INC12 tx · $72.9K · Jun 24, 2026
Edge Therapeutics, Inc.9 tx · $100K · Mar 3, 2026
Aclaris Therapeutics, Inc.114 tx · $4.3M · Jan 5, 2022

Track record of Ali-Jackson Kamil

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Ali-Jackson Kamil

Co-insiders of Ali-Jackson Kamil

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
RIGEL PHARMACEUTICALS INC	Jun 24, 2026	Sell	-2,500	35.00 USD	—	SEC
RIGEL PHARMACEUTICALS INC	May 28, 2026	Sell	-2,500	29.17 USD	$72.9K	SEC
RIGEL PHARMACEUTICALS INC	May 19, 2026	Award	5,750	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Mar 3, 2026	AwardD	54,876	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Jun 11, 2025	AwardD	22,700	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 28, 2025	Award	2,500	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 28, 2025	AwardD	3,000	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Jun 25, 2024	AwardD	9,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 29, 2024	Award	25,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 29, 2024	AwardD	30,000	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Jul 17, 2023	AwardD	9,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	Jul 12, 2023	Award	25,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	Jul 12, 2023	AwardD	30,000	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Jun 29, 2022	AwardD	9,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 23, 2022	AwardD	22,500	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 23, 2022	Award	18,750	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	ExerciseD	-27,905	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	ExerciseD	-6,638	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	Exercise	27,905	—	—	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	ExerciseD	-7,100	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	Exercise	3,875	—	—	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	Exercise	6,638	—	—	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	ExerciseD	-3,875	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	Exercise	7,100	—	—	SEC
RIGEL PHARMACEUTICALS INC	Dec 17, 2021	AwardD	120,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
RIGEL PHARMACEUTICALS INC	Jun 24, 2026	Sell	-2,500	35.00 USD	—	SEC
RIGEL PHARMACEUTICALS INC	May 28, 2026	Sell	-2,500	29.17 USD	$72.9K	SEC
RIGEL PHARMACEUTICALS INC	May 19, 2026	Award	5,750	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Mar 3, 2026	AwardD	54,876	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Jun 11, 2025	AwardD	22,700	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 28, 2025	Award	2,500	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 28, 2025	AwardD	3,000	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Jun 25, 2024	AwardD	9,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 29, 2024	Award	25,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 29, 2024	AwardD	30,000	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Jul 17, 2023	AwardD	9,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	Jul 12, 2023	Award	25,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	Jul 12, 2023	AwardD	30,000	0.00 USD	$0	SEC
Edge Therapeutics, Inc.	Jun 29, 2022	AwardD	9,000	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 23, 2022	AwardD	22,500	0.00 USD	$0	SEC
RIGEL PHARMACEUTICALS INC	May 23, 2022	Award	18,750	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	ExerciseD	-27,905	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	ExerciseD	-6,638	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	Exercise	27,905	—	—	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	ExerciseD	-7,100	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	Exercise	3,875	—	—	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	Exercise	6,638	—	—	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	ExerciseD	-3,875	0.00 USD	$0	SEC
Aclaris Therapeutics, Inc.	Jan 5, 2022	Exercise	7,100	—	—	SEC
RIGEL PHARMACEUTICALS INC	Dec 17, 2021	AwardD	120,000	0.00 USD	$0	SEC